Lilly and Novo show GLP-1s slowing biological aging clocks, hinting at first blockbuster longevity drug
rand_longevity · x · 2026-10-31
The poster claims that both Lilly and Novo have shown their GLP-1 drugs slowing biological aging clocks, arguing the first blockbuster longevity drug may already be here. The post is a single line with no trial data or sources, so treat it as an early signal rather than a confirmed result.
More from Research
- Bandits meet LLMs: combining multi-armed bandits with LLMs for adaptive, efficient AI — burkov · 2026-10-31
- Open-source lidar_slam_ros2 adds multi-session map joining without GPS or initial guess — rsasaki0109 · 2026-10-31
- Stanford CS312 write-up explains sharpness and the edge of stability in pretraining — stanfordnlp · 2026-10-31
- Google quantum chip solves in 5 minutes a task that would take 10 septillion years — acmoytoy · 2026-10-31
- 19 LLMs play 376 rounds of a Codenames-style game: guessing matters more than clueing — Hardicecream17 · 2026-10-31
- Lacuna's Standing On traces any repo's research roots — nanoGPT stands on 140 papers — hugo_larochelle · 2026-10-31